Graf Susan E
SEC insider (Form 3/4/5 filer). CIK 0001577637. Director at Aardvark Therapeutics, Inc. (AARD) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Aug 14, 2026. Located in SAN DIEGO, CA.
Companies Graf Susan E has filed insider reports for
- Aardvark Therapeutics, Inc. (AARD): Director
- CG Oncology, Inc. (CGON): Director
Graf Susan E
CIK: 0001577637
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Aug 14, 2026AARD
Aardvark Therapeutics, Inc.
AwardDirectStock Option (right to buy)
45K shares- - Jun 4, 2026CGON
CG Oncology, Inc.
AwardDirectDirector Stock Option (right to buy)
9.4K shares- - Jun 11, 2025AARD
Aardvark Therapeutics, Inc.
AwardDirectStock Option (right to buy)
30.5K shares- - Jun 5, 2025CGON
CG Oncology, Inc.
AwardDirectDirector Stock Option (right to buy)
24.2K shares- - Oct 4, 2024CGON
CG Oncology, Inc.
AwardDirectStock Option (Right to Buy)
15.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 14, 2026 |  AARD Aardvark Therapeutics, Inc. | Award Stock Option (right to buy) | 44,964 | - | - | Direct |
| Jun 4, 2026 |  CGON CG Oncology, Inc. | Award Director Stock Option (right to buy) | 9,354 | - | - | Direct |
| Jun 11, 2025 | AARD Aardvark Therapeutics, Inc. | Award Stock Option (right to buy) | 30,508 | - | - | Direct |
| Jun 5, 2025 | CGON CG Oncology, Inc. | Award Director Stock Option (right to buy) | 24,165 | - | - | Direct |
| Oct 4, 2024 | CGON CG Oncology, Inc. | Award Stock Option (Right to Buy) | 15,600 | - | - | Direct |
1-5 of 5 transactions